Dr. Eszter Nagy
Research & Development
Eszter Nagy, MD, PhD, has spent 18 years in biotechnology and has been involved in the discovery and development of numerous biologics for infectious diseases. Her research and development experience includes bacterial pathogenesis, immune response to infections, protein-based vaccines for bacterial pathogens, vaccine adjuvants and anti-infective monoclonal antibodies.She founded Arsanis in 2010 and built a multi-disciplinary research and pre-clinical team in Vienna that created the current pipeline of the company, including Phase 2 readiness of the leading program ASN100. She was Associate Professor at the University Medical School of Pécs and a Visiting Scientist in the Department of Cancer Genetics at the Roswell Park Cancer Institute and received her MD and PhD from the University Medical School of Pécs, Hungary, and was a Postdoctoral Fellow at Dartmouth Medical School.